The company applied for the approval around two weeks ago, said Dr Syed Modasser Ali, the chairman of Bangladesh Medical Research Council. India on Jan 3 approved COVAXIN along with COVISHIELD, the vaccine developed by the UK’s University of Oxford and Swedish-British drugmaker AstraZeneca, for emergency use. Bharat Biotech developed COVAXIN jointly with the Indian Council of Scientific Research. India is also producing the Oxford vaccine, of which Bangladesh has ordered 30 million doses. Besides Bharat Biotech, China’s Anhui Zhifei Longcom Biopharmaceuticals has applied for clinical trials of its vaccine in Bangladesh.

Source: bd News24 January 22, 2021 17:48 UTC